Fudan University Shanghai Cancer Center
Shanghai, China
Key Insight: In 2024, the hospital achieved an overall 5-year survival rate of 71.8%, on par with developed countries, and ranked 1st globally in proton and heavy-ion single-device treatment volume (1,211 cases).
Pioneering Oncology &
Precision Cancer Care
Fudan University Shanghai Cancer Center operates as a highly integrated network across its Xuhui and Pudong campuses, directly linked with the Shanghai Proton and Heavy Ion Hospital.
The hospital leads globally in specialized surgeries, with its Pancreatic Surgery Department completing over 2,500 resections annually. Prof. Shao Zhimin's team has revolutionized triple-negative breast cancer care with the "Fudan Classification," further cementing the institution's role as a beacon of precision medicine.
Host Unit
National Oncology Regional Medical Center (Fujian)
Institutional Status & External Evidence
National Key Disciplines & Specialties
Oncology
MOE Key Discipline; overall 5-year survival rate of 71.8%, leading the nation in comprehensive cancer treatments.
Pathology
MOE Key Discipline; ranked 2nd nationally, providing the foundational diagnostic precision for all surgical and medical oncology.
Pancreatic Tumors
National Clinical Key Specialty; performs over 2,500 resections per year with nearly 70% utilizing minimally invasive techniques.
Breast Cancer
MOH Key Discipline; pioneered the "Fudan Classification" for precision triple-negative breast cancer treatment.
Radiation Therapy
MOH Key Discipline; the only institution in China seamlessly combining photon, proton, and heavy-ion therapies.
Integrative Chinese-Western Medicine
National Clinical Key Specialty enhancing patient recovery, symptom management, and holistic oncological care.
Medical & Research Innovation Hubs
Special Needs Clinic & Global Referrals
FUSCC delivers specialized care to international and premium domestic patients through its Special Needs Clinic. Furthermore, it operates a robust bidirectional international referral network anchored by 8 top-tier global Sister Hospitals.
- Direct clinical collaborations with MD Anderson, Princess Margaret, and Gustave Roussy.
- Regular international expert joint clinics and highly specialized MDT remote consultations.
- Publishes the esteemed English-language journals 'Journal of Radiation Oncology' and 'Precision Cancer Medicine'.
Global Excellence Standard
By integrating global expertise and leading multi-institutional clinical trials, the hospital guarantees that international patients have rapid access to the most sophisticated oncological care available.
Worldwide Referrals
Pioneering cross-border oncology delivery and continuous clinical excellence in China.
Source & Verification
Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.